Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206920 · ClinicalTrials.gov registry record
The DC Cohort Longitudinal HIV Status Neutral Study
A clinical trial of HIV and AIDS, sponsored by George Washington University.
- Recruiting
- Registry status
- 19,000
- Enrollment target
- 14
- Study locations
NCT01206920 is a study of HIV and AIDS that is actively recruiting participants, run by George Washington University. The registered enrollment target is 19,000 participants, above the 377-participant average among 303 other HIV trials with a reported enrollment target (4940% higher). The trial reports 14 study locations across 1 state.
The verdict
NCT01206920, a study of HIV and AIDS, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- 19,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.
Study Locations (14)
District of Columbia
- Kaiser Permanente Mid-Atlantic States - Washington D.C.
- Unity Health Care - Washington D.C.
- Georgetown University - Washington D.C.
- La Clinica Del Pueblo - Washington D.C.
- Whitman-Walker Health - Washington D.C.
- Children's National Medical Center--Pediatric Clinic - Washington D.C.
- Washington Hospital Center - Washington D.C.
- Washington Health Institute - Washington D.C.
- Family and Medical Counseling Service - Washington D.C.
- George Washington Medical Faculty Associates - Washington D.C.
- Howard University Hospital--Adult Clinic - Washington D.C.
- Howard University Hospital--Pediatric Clinic - Washington D.C.
- Veterans Affairs Medical Center - Washington D.C.
- Us Helping Us, People into Living, Inc. - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,000 participants |
| Start Date | 2011-01 |
| Est. Completion | 2041-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206920
The ClinicalTrials.gov registry entry for NCT01206920 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 19,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 377-participant average among 303 other HIV trials with a reported enrollment target (4940% higher). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 0 interventions.
NCT01206920 reports 14 study locations spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01206920 about?
NCT01206920 is a clinical study titled "The DC Cohort Longitudinal HIV Status Neutral Study". The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and...
What is the current status of trial NCT01206920?
This trial is currently recruiting. The enrollment target is 19,000 participants. The study started on 2011-01. Estimated completion is 2041-01.
What conditions does trial NCT01206920 study?
This clinical trial studies the following conditions: HIV, AIDS.
Who is sponsoring clinical trial NCT01206920?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01206920 being conducted?
This trial has 14 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transitional Housing and HIV Health
RECRUITING
-
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RECRUITING · Phase 1
-
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RECRUITING
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.